NCT02451527View on ClinicalTrials.gov

The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

July 31, 2016

Conditions
Healthy
Interventions
DRUG

Digoxin

Digoxin 0.5mg tablet by mouth on Day 1 and Day 38

DRUG

PEX168

PEX168 in subcutaneous injection on Day8，15，22，29 and Day 36

Trial Locations (1)

710061

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

All Listed Sponsors
lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER

NCT02451527 - The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy Subjects | Biotech Hunter | Biotech Hunter